LATEST NEWS: Allergan ruling casts doubt on tribal patent strategy - (Reuters) - A U.S. judge’s ruling on Monday invalidating Allergan Plc's patents on its blockbuster $1.5 billion dry-eye medicine, Restasis, has cast doubt on the company's novel strategy to enlist a Native American tribe to help shield those patents from challenge by generic drugmakers, legal experts said.
LATEST NEWS: New cancer drugs help Johnson & Johnson top profit estimates - (Reuters) - Johnson & Johnson posted better-than-expected third-quarter earnings, raising its full-year forecast due to growth from new cancer drugs and high-margin treatments picked up in its $30 billion acquisition of Actelion earlier this year.
LATEST NEWS: Trump's drug czar nominee withdraws from consideration - WASHINGTON (Reuters) - The U.S. lawmaker who was President Donald Trump's pick for drug czar withdrew on Tuesday after it became public he spearheaded a bill that hurt the government's ability to crack down on opioid makers flooding the market with the addictive painkillers.
LATEST NEWS: Florida needs more pet-friendly hurricane shelters for the elderly - (Reuters Health) - When pet owners need to flee from disasters like hurricanes and fires, they often think first of their animals, but a new study suggests a scarcity of pet-friendly emergency shelters could make older evacuees all the more vulnerable.
LATEST NEWS: UnitedHealth sees growth in 2018, opportunities in Trump plans - (Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, said earnings will grow 13 to 16 percent in 2018 as medical costs remain low, and that it expects to benefit from new insurance products backed by U.S. President Donald Trump.